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Abstract: The majority of US adults 
are overweight or obese, which is a pri­
mary risk factor for type 2 diabetes and 
other chronic diseases. Recent advances 
in behavioral treatment of obesity have 
produced significant short- and long-
term weight losses that reduce the risk 
of type 2 diabetes and cardiovascular 
disease. This article reviews key compo­
nents of effective behavioral treatment 
interventions, including diet, exercise, 
and behavioral and psychosocial strat­
egies. The authors review newer treat­
ment modalities that may enhance 
dissemination (Internet, smartphone) 
and discuss applications to clinical 
practice. Practitioners face multiple 
barriers to effectively delivering lifestyle 
interventions in today’s health care set­
ting but, nonetheless, remain powerful 
motivators in helping patients initiate 
and maintain weight loss efforts that 
reduce the risk of type 2 diabetes and 
other chronic diseases. 
Keywords: weight loss; physical activ­
ity; diet; lifestyle 
Introduction 
Obesity and type 2 diabetes are com­
mon, chronic disorders with major pub­
lic health implications. Obesity affects 
approximately 33% of the adult US pop­
ulation1-3 and is a primary risk factor for 
cardiovascular disease (CVD), hyperten­
sion, insulin resistance, and dyslipidemia 
(high triglycerides, high LDL cholesterol, 
and low HDL cholesterol).4-6 Type 2
diabetes is a similarly prevalent disor­
der, affecting an estimated 25 million
American adults (6.8% of population)
and another 79 million who have pre-
diabetes, or impaired fasting glucose.7 
Type 2 diabetes is a known risk factor
for CVD, stroke, and all-cause mortality
as well as lower-limb amputations, kid­
ney failure, and cognitive dysfunction
and dementia.8 
Lifestyle intervention treatment
“packages” have been evaluated
in several clinical trials and have
shown positive long-term results
on health outcomes. 
It is well accepted that obesity is 
related to the development of type 2 
diabetes.1,9-11 Obese adults, relative to 
those of normal weight, have a 3 times 
higher prevalence of type 2 diabetes.3,12 
Morbidly obese adults (obesity class 3; 
BMI >40 kg/m2), compared with normal 
weight adults, fair much worse and have 
up to a 7 times higher prevalence of type 
2 diabetes.3,12 Gradual weight gain lead­
ing to obesity also increases the risk for 
developing type 2 diabetes5 because for 
each 1 kilogram increase in weight there 
is an approximate 9% increase in the rel­
ative risk for diabetes.13 
Overweight and obese individuals with 
diabetes who attempt weight reduction 
face considerable challenges. However, 
new advances in behavioral treatment of 
obesity have enabled significant short-
and long-term weight losses that appear 
to lower the risk of developing type 2 
diabetes and can result in improved gly­
cemic control and CVD risk factors in 
individuals with diabetes.14-16 This article
reviews the key components of effective
behavioral weight control interventions
that may reduce diabetes risk
   
 
 
 
 
 
 
 
factors and improve complications of type
2 diabetes. We review the components
of successful short- and long-term inter­
vention approaches that target diet, exer­
cise, and behavioral changes in adults. 
We will conclude with newer modali­
ties (eg, online interventions) that may 
further enhance the dissemination and 
effectiveness of long-term weight control 
interventions. Although pharmacologi­
cal interventions and bariatric surgery are 
effective at decreasing body weight and 
lowering the risk for type 2 diabetes,17,18 
we focus our review on nonpharmaco­
logical and nonbariatric lifestyle inter­
vention approaches. Moreover, because
obesity and development of type 2 diabe­
tes are significant concerns for children, 
we refer the reader to several recent, 
excellent reviews on the topic of pediat­
ric weight control.19-22 
Benefits of Weight Loss 
Weight loss clearly has beneficial 
effects on reducing several CVD risk fac­
tors, including, but not limited to, low­
ering blood pressure, triglycerides, and 
total and LDL cholesterol and increasing 
HDL cholesterol.6,12,15,23,24 Weight loss has 
also been associated with a significant 
reduction in the prevalence of abdomi­
nal obesity,25 sleep apnea,26 and urinary 
incontinence.27 There are also positive 
effects of weight loss on psychosocial 
variables, including reductions in depres­
sion and anxiety28,29 and improvements in 
body image.30 
Notably, weight loss also has several 
established benefits on development and 
management of type 2 diabetes. Several 
large randomized controlled trials (see 
below for more detail) have demon­
strated convincingly that lifestyle inter­
vention with a modest amount of weight 
loss (5%-7%) reduces the incidence of 
type 2 diabetes.14,31 Moreover, dietary 
changes, physical activity, and their com­
bination can result in improved glycemic 
control and CVD risk factors in individ­
uals with preexisting diabetes.14 Weight 
loss increases insulin action, improves 
glucose control, decreases fasting glucose 
and insulin concentrations, and lowers 
the dose of diabetes medication.14,16,32-34 
Thus, weight loss is highly recom­
mended for overweight (BMI = 25.0­
29.9 kg/m2) and obese (BMI ≥ 30 kg/ 
m2) adults at risk for type 2 diabetes or 
adults with type 2 diabetes.35 Although 
larger weight losses produce greater ben­
efits in blood glucose,34,36 small weight 
losses of 5% to 10% in even very over­
weight persons will produce significant 
improvement in diabetes-related health 
parameters and CVD risk factors14-16 and 
is achievable and obtainable for most 
adults through lifestyle interventions. In 
general, glucose concentrations and other 
health outcomes improve with reduced 
energy intake before appreciable weight 
loss occurs, but long-term weight loss 
seems to further enhance glucose and 
diabetes health parameters.14,37 
Key Components of 
Effective Lifestyle 
Interventions 
Lifestyle intervention treatment “pack­
ages” have been evaluated in several 
clinical trials and have shown posi­
tive long-term results on health out­
comes.31,38-41 Most programs achieve 
average weight loss of 7 to 10 kg (7%­
10% of initial body weight) at 6 months— 
most of which is maintained through  
12 months.42 Longer-term behavior trials, 
such as the Diabetes Prevention Program 
(DPP)31 and the Look AHEAD (Action for 
Health in Diabetes) trial,43 have found 
clinically significant weight losses averag­
ing 4% to 5% (or 4-5 kg) at 3- to 4-year 
follow-ups. Although it is difficult to 
tease apart the precise components that 
contribute to success, research has identi­
fied some of the more salient features of 
lifestyle intervention programs, including 
dietary, physical activity, behavioral, and 
psychosocial strategies (Table 1). 
Dietary Prescriptions 
Patients in behavioral weight loss pro­
grams are given calorie and fat gram 
goals designed to produce a weight loss 
of about 2 lb per week. The dietary
prescriptions used have been derived
from a large number of research studies
comparing different degrees of caloric 
restriction and different macronutrient  
distributions.44,45 Typically, programs use 
calorie goals of 1200 to 1800 kcal/d, with 
the higher goal reserved for individuals 
who weigh more than 200 lb. Very-low­
calorie diets (VLCDs) with <800 kcal/d 
were once popular and shown to pro­
duce weight losses of approximately 20 
lb in 12 weeks.46 However, weight regain 
often occurred when foods were rein­
troduced into the diet, and in the long 
term, patients treated with programs that 
combined behavior modification with 
VLCDs had weight loss comparable with 
those achieved in behavioral programs 
with balanced 1000- to 1800-kcal/d diets 
throughout.47,48 Thus, the field today has 
moved away from the VLCD regimens 
and now prescribes balanced deficit diets 
of 1200 to 1800 kcal/d. 
The fat goal is typically 30% of calo­
ries from fat and is usually prescribed 
to patients in grams per day to facili­
tate self-monitoring. A focus on reducing 
dietary fat consumption is partly because 
of the evidence that overweight individ­
uals49,50 and individuals with type 2 dia­
betes51 have higher consumption of fat. 
Moreover, fat is more energy dense com­
pared with other macronutrients (ie, fat 
has 9 kcal/g, and carbohydrate and pro­
tein have only 4 kcal/g). Several stud­
ies44,45 have found better weight losses 
when patients were given both calorie 
and fat gram goals than either goal alone. 
Thus, most behavioral treatment pro­
grams focus on reducing both calorie and 
fat intake. 
Limiting carbohydrates (rather than fat) 
may also promote weight loss. Several 
studies have been conducted compar­
ing low-carbohydrate diets (such as the 
Atkins diet) with low-fat regimens.52-56 
One study included a significant pro­
portion of patients with type 2 diabe­
tes.56 In general, the long-term results 
from these studies indicate similar weight 
losses between the different types of reg­
imens (ie, low fat vs low carbohydrate). 
For example, results of a 2-year study, in 
which 307 obese participants who were 
randomly assigned to a low-carbohydrate 
or a low-fat diet, indicated weight losses 
of 11 kg (11%) at 1 year and 7 kg (7%) at 
2 years, which did not significantly differ 
between the 2 dietary regimens.52 What 
  
 
 
 
 
 
 
 
 
 
 
 
  
Table 1. 
Variables Associated With Successful Weight Control. 
Dietary Low-calorie, low-fat diet 
Meal replacements/Structured meal plan 
Physical activity High physical activity goals (60-90 min/d) 
Short (∼10 minute) bouts of physical activity 
Exercise equipment in the home 
Behavioral Daily self-weighing of body weight 
Daily monitoring of food intake 
Goal setting 
Stimulus control 
Psychosocial Social support 
Relapse prevention/Cognitive strategies 
Continued patient-provider 
contact 
Monthly or more frequent visits 
appears to affect weight loss in these
studies is not the macronutrient distribu­
tion but rather the level of adherence to
the regimen (and ultimately the number
of calories that are consumed). Although
weight losses achieved with very different
macronutrient diets appear to be similar,
those participants who are most adherent
to any of the diets lose the most weight.57 
Promoting adherence to dietary 
prescriptions. Rather than simply 
telling patients to eat 1200 to 1800 
cal/d, researchers have shown that 
incorporating frozen entrées or liquid 
formulas for some of the meals may help 
improve adherence to the calorie goals 
and consequently improve weight loss 
outcomes. Typical meal replacement 
programs fix the intake of 1 or 2 meals 
per day with a calorie-controlled, 
nutritionally balanced liquid shake and 
allow self-selected additional meals and 
snacks. In obese patients, diets with meal 
replacements have proven to be more 
effective than conventional diets. Wadden 
and Frey58 used a balanced deficit diet 
that consisted of 4 servings daily of 
liquid meal replacement (150 kcal each) 
and a prepackaged dinner entrée (about 
300 kcal) with salad. Those using this 
diet as part of an intensive behavioral 
program lost 14.5 kg after 17 weeks and 
maintained the weight loss at 1 year. In 
another study of overweight patients, 
those on the meal replacement regimen 
lost 7.3% after 3 months and 8.4% after 
4 years, whereas the patients on the 
conventional diet had lost 1.4% and 3.2% 
at the same respective time points.59 
Meal replacements also offer a prom­
ising strategy for treating obese patients 
with type 2 diabetes. In one study of 
overweight patients with type 2 diabe­
tes, patients in the meal replacement 
group achieved average weight losses of 
5.2% at 6 months and 4.4% at 12 months, 
respectively, compared with 2.9% and 
2.4% weight losses among patients pre­
scribed an individualized dietary plan.59 
The ongoing Look AHEAD trial of 5145 
individuals with type 2 diabetes has also 
incorporated meal replacements into the 
dietary plan and achieved clinically sig­
nificant, long-term weight losses through 
4 years of follow-up. 
More structured regimens appear to 
facilitate greater weight losses by chang­
ing the types of food stored in the home, 
creating a more regular pattern of meal 
eating, reducing difficulty with estimat­
ing portion size and planning meals, 
and helping control eating when not 
hungry.60,61 
Physical Activity 
Regular physical activity generally 
results in modest, if any, initial weight 
loss62-66 but is critical in maintain­
ing weight loss and preventing weight 
regain.67,68 Randomized studies evaluat­
ing diet alone (restricting food intake), 
exercise alone, and the combination 
of diet and exercise have consistently 
shown that combining diet and exercise 
results in the most weight loss.63 Exercise 
(∼60 min/d) is also the best predictor of 
weight loss maintenance.62,68 Independent 
of weight control, physical activity has 
several additional important health ben­
efits; it increases cardiorespiratory fit­
ness,69,70 increases insulin action,71,72 
improves glucose control,14,16 and is 
related to a decreased risk for type 2 dia­
betes.73,74 Furthermore, exercise decreases 
the risk for CVD75 and promotes a favor­
able lipid panel (lower triglycerides, total 
cholesterol, and LDL cholesterol and 
higher HDL).76 
Physical activity recommendations dif­
fer depending on the goals of an individ­
ual patient (eg, to lose weight, to prevent 
CVD risk factors, or prevent weight 
regain). In 2008, the Physical Activity 
Guidelines Advisory Committee Report 
recommended that adults participate in 
30 minutes per day, 5 days per week of 
moderate-intensity aerobic exercise (eg, 
brisk walking) to reduce the risk for CVD 
and other metabolic diseases.77 This phys­
ical activity recommendation is corrob­
orated by other health organizations, 
including the American College of Sports 
Medicine (ACSM), the American Diabetes
Association (ADA), the American Heart
Association, and the World Health
Organization.62,78-80 However, this dose of
exercise (ie, 30 min/d, 5 d/wk or
150 min/wk) is recommended to reduce 
the risk for disease and is likely insuffi­
cient to lose weight or maintain weight 
loss. The Institute of Medicine67 currently 
recommends 60 min/d every day of the 
week to maintain a healthy BMI and 
60 to 90 min/d to promote weight loss 
maintenance. 
Brisk walking is the most common type 
of exercise and is typically recommended 
in behavioral interventions and by pub­
lic health guidelines.62,67,78-80 Some public 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
health organizations recommend strength 
training in addition to walking (ADA, 
ACSM). For example, the ACSM devel­
oped the first public health guideline for 
adults to participate in regular strength 
training (ie, lifting weights).79,80 Even 
though adding strength training to an aer­
obic exercise program may not result in 
greater weight loss,81 strength training 
increases blood flow to active muscle,82 
insulin action,82 and muscular strength79,80 
and is a necessary component of a physi­
cal activity program. 
For promoting weight loss and main­
tenance, many randomized studies have 
shown that higher doses of exercise 
result in the best outcomes. Jakicic et al83 
found that women in a behavioral inter­
vention reporting higher amounts of 
physical activity (ie, >200 min/wk) had 
greater weight losses at 6, 12, and 18 
months compared with women with ≤150 
min/wk of exercise (−13.1 kg vs −3.5 kg, 
respectively). Similarly, Jeffery et al84 ran­
domly assigned 202 overweight adults to 
a behavioral intervention focused on a 
1000 or 2500 kcal/wk exercise goal. The 
2500 kcal/wk exercise group, relative to 
the 1000 kcal/wk group, reported signif­
icantly higher exercise levels and greater 
weight losses at 12 (−8.5 kg vs 6.1 kg, 
respectively) and 18 (−6.7 kg vs 4.1 kg, 
respectively) months. However, after the
intervention stopped at 18 months, activity
declined in the higher exercise goal group,
and there was no difference between
groups in exercise and body weight loss
at 30 months.85 Thus, there may be more
barriers to exercise with higher doses, and
continuing to participate in a behavioral
intervention may be necessary to maintain
higher amounts of exercise. 
Promoting adherence to exercise goals. 
Higher levels of physical activity are 
related to better long-term weight loss 
outcomes, so the question becomes, 
“How best to encourage overweight 
individuals to adopt and maintain a 
higher level of physical activity?” One 
approach may be to encourage more 
flexible exercise routines. Jakicic
et al86 conducted a study in which 
all women received the same diet, 
the same behavioral program, and 
the same exercise goals. However, a 
long-bout group did their exercise in
one 40-minute bout, whereas a short-
bout group was instructed to exercise
in four 10-minute bouts. The short
bout exercise prescription led to better
exercise adherence; these participants
were more likely to exercise on any
given day and completed more minutes
of exercise over the course of the
program. Their weight losses were
also somewhat better. Interestingly,
the short- and long-bout groups
had comparable improvements in
cardiovascular fitness. Accumulating
multiple daily short bouts of exercise
(10 minutes, 3 times/d) may be easier
for obese adults to achieve and result in
long-term exercise adherence.83 
Another way to improve exercise adher­
ence is to modify the environmental cues 
for physical activity. Cross-sectional and 
descriptive studies suggest that exercise 
levels are higher when exercise equip­
ment is in the home.87,88 Similarly, Jakicic 
et al83 showed that overweight women 
randomly assigned to exercise with home 
exercise equipment (vs exercise with­
out home exercise equipment) showed 
higher exercise adherence and experi­
enced greater weight and body fat loss. 
Taken together, these data suggest that 
having exercise equipment in the home 
may be a convenient way for individu­
als to accumulate multiple bouts of exer­
cise and meet current physical activity 
recommendations. 
Home-based exercise programs also 
appear to promote better adherence than 
supervised exercise in a controlled labo­
ratory setting.83,89 Perri et al89 found that 
in obese women after 12 months, home-
based exercise increased exercise par­
ticipation and adherence compared 
with supervised exercise. Also, in obese 
women, 12-month weight losses were 
greater with home-based exercise relative 
to supervised exercise (11.6 vs 7.0 kg, 
respectively). 
Behavioral Strategies 
Behavioral strategies typically include a 
combination of goal setting, self-
monitoring with feedback, stimulus con­
trol, and relapse prevention/problem 
solving,39,40 as described below. 
Self-monitoring. Self-monitoring of diet 
is often considered the single most 
important component of a behavioral
weight control program.90,91 Patients are
taught to write down everything they
eat, to estimate or count calories in those
foods by reading food labels or using a
resource, and to record a running total
of their calorie intake to ensure they
stay within their calorie goal. Patients
also write down each type of exercise,
including minutes of time spent exercising
and the number of steps taken each day,
as tracked by a pedometer. The patient is
then taught to use the diary to evaluate
their current behavior, identify problems,
and select specific behaviors to target
for change. Interventionists review food
and activity records and provide specific
guidance on choices and supportive
feedback to the patient.39,40 A number of
clinical trials have found self-monitoring
to be significantly correlated with short-
and long-term weight loss outcomes.91,92 
Participants are also given a weight 
goal and told to weigh themselves and 
to track progress toward their goal on 
a weight graph. Several studies have 
now shown that frequent self-weighing
is a significant and independent predic­
tor of weight loss, less weight regain, 
and avoidance of initial weight gain in 
adults.93,94 Daily self-weighing appears to 
promote the best weight control when 
combined with behavioral treatment pro­
grams.93,95,96 Of note, frequent self-
weighing is not associated with an 
increase in adverse psychological out­
comes, including depressive symptoms, 
eating disorders, or binge eating.97 
Although adherence to self-monitoring 
tends to wane over time,98 the advent of 
new technologies, such as the Internet, 
PDAs, and smartphones, may make the 
task of self-monitoring easier for patients. 
Patients are able to look up the calo­
ries in a database and save the data to 
an online record. Similarly, a variety of 
instruments are now available that can 
provide objective measures of physical 
activity. These instruments may not only 
make self-monitoring easier but also pro­
vide a way for interventionists to monitor 
patients’ behaviors in real time and pro­
vide helpful guidance and support.99 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Goal setting. Typically, in behavioral 
weight loss programs, participants are 
given goals for calorie and fat, and 
physical activity, and asked to monitor 
and modify these aspects of their 
behavior. Although the overall behavioral 
goals are quite general (eg, eat 1500 kcal/d,
<30% from fat, and exercise  
200 min/wk), more specific daily goals 
(eg, use jam instead of butter on bread) 
help break the behavior change into 
small, achievable steps rather than a 
general goal, such as to eat less fat. 
Stimulus control. Given the role of 
environmental factors in influencing 
weight, lifestyle programs typically teach 
stimulus control techniques to reduce 
the cues for inappropriate behaviors 
and strengthen the cues for appropriate 
eating and activity. Stimulus control 
techniques are designed to reorganize 
the environment to support desired 
behaviors. Patients are taught that it is 
difficult to consistently make good eating 
and exercise choices in an environment 
that does not support these behaviors. 
Thus, they are instructed to reduce or 
eliminate cues that encourage overeating/ 
inactivity (eg, remove chips, desserts, or 
other tempting foods from the house and 
reduce the number of TVs in the home) 
and to make it as easy as possible to 
make good choices (eg, leave exercise 
equipment in a highly visible area and 
have low-fat snacks readily available in 
the refrigerator). 
Psychosocial Strategies 
Cognitive techniques. Cognitive therapy, 
when combined with diet and exercise 
interventions, produces superior weight 
losses than diet and exercise treatment 
alone.38 Thus, the cognitive component 
is often added to effective treatment 
packages. Cognitive approaches to 
weight loss focus on identifying and 
modifying maladaptive thoughts or self-
perceptions associated with overeating 
and inactivity, prior relapses, or prior 
treatment failures. Patients are taught 
to identify and change the maladaptive 
thoughts and emotions that can 
contribute to overeating and inactivity, 
including dichotomous thinking (eg, “If I 
can’t eat healthy at every meal, I might as 
well not do it at all”) and rationalizations 
(eg, “I’ve had a hard day, I deserve a 
piece of cake”). Patients are taught to 
replace these negative thoughts with 
more positive and helpful self-statements. 
Relapse prevention. Based on Marlett and
Gordon’s relapse prevention model,100 
patients are taught to identify specific
situations that might pose problems for
dietary or exercise adherence. Three
common types of high-risk situations
are situations involving food cues (eg,
being in a restaurant or a family meal),
situations involving affective cues (eg,
anger and depression), and situations
involving boredom or transition (eg,
watching TV). Patients are taught to
use behavioral coping strategies (such
as leaving the room) and cognitive
coping responses (devaluing the food)
to prevent lapses from turning into
relapses. Similarly, they are taught to use
problem-solving techniques to overcome
these and other barriers to their desired
goals.101 
Providing participants with training 
in relapse prevention and with contin­
ued therapist contact improves long-term 
weight maintenance.102 Relapse preven­
tion training was provided to 1 group 
during the last 6 weeks of the treat­
ment program; these participants were 
taught about the process of relapse and 
practiced skills needed to identify and 
cope with high-risk situations and to 
recover from acute lapses. The group that 
received both relapse-prevention training 
and continued therapist contact had sig­
nificantly better weight maintenance than 
any other group.102 
Social support. Social support has long 
been studied as a way to improve 
motivation for long-term weight loss. 
Overall, findings on the effects of social 
support suggest a small positive effect.103 
Wing and Jeffery104 examined the effects 
of recruiting patients with friends and 
providing a social support–focused 
treatment; the best weight losses were 
found in those individuals who were 
recruited with friends and provided 
with the social support intervention. 
However, other studies have shown 
more mixed results for social support. 
A meta-analysis of 21 articles examined 
the role of family support in weight 
loss and found inconclusive results; yet 
spouse involvement appeared to increase 
effectiveness.105 Interestingly, Gorin and 
colleagues106 showed that there is a 
ripple effect of participating in a weight 
loss program; not only do participants 
in a weight loss program lose weight, 
but their spouses do too, even though 
they do not attend meetings. Moreover, 
the greater the weight loss of the 
participant, the greater the weight loss 
in the spouse. Based on findings such 
as this, a common treatment strategy 
has been to ask spouses to actually 
participate in the weight loss program 
along with the participant and to make 
the same changes in eating and exercise 
behavior. Overall, support from social 
context is often helpful but can, for some 
patients, interfere with long-term weight 
management. 
Ongoing Patient-Provider 

Contact
 
Contact with a practitioner appears to 
be the most effective approach to helping 
patients maintain their behavior changes. 
Several studies have shown the bene­
fits of continuing to attend weight con­
trol classes in the long term.48,101,107,108 
Continued contact (typically weekly for 
6 months and every 2 weeks or monthly 
thereafter) seems to provide patients 
with the support and motivation needed 
to continue to practice weight control 
behaviors, such as diet monitoring and 
exercising regularly. The nature of con­
tact (ie, individual vs group meetings) 
appears to be less important than con­
tinuing to see patients, but one random­
ized controlled trial found that group 
treatment induced a significantly larger 
weight loss than individual care, even in 
patients who indicated a preference for 
and received individual treatment.109 
Lifestyle Intervention 
Trials: Long-term Results 
As noted earlier, several large, ran­
domized controlled trials have now doc­
umented the long-term outcomes of 
 
 
   
 
 
 
comprehensive lifestyle intervention pro­
grams on weight loss, diabetes, and CVD 
outcomes. The 3 largest randomized con­
trolled trials are the US DPP,14 the Finnish 
Diabetes Prevention Study (DPS), and 
the Look AHEAD trial.16,32,110 All stud­
ies included a comprehensive behavioral 
weight loss program, as described above. 
The US DPP14 is the largest randomized 
trial to examine whether a comprehen­
sive lifestyle intervention could prevent 
the progression of prediabetes to diabe­
tes in 3234 overweight/obese individuals 
with prediabetes with impaired glucose 
tolerance. Participants were randomly 
assigned to lifestyle intervention, metfor­
min (most commonly prescribed antidi­
abetes medication), or placebo (control) 
groups. The goals for the lifestyle group 
were to lose ≥7% of body weight by eat­
ing a low-calorie (1200-1800 kcal/d), 
low-fat (<30%) diet and exercising >150 
minutes per week. In the lifestyle group, 
the behavioral intervention included 16 
lesson plans incorporating diet, exercise, 
and behavioral modification to achieve 
group goals. Study interventionists met 
with participants weekly during the ini­
tial 24 weeks and at least bimonthly for 
the next 4 years. The metformin group 
received a dose of 850 mg twice daily 
plus a standard lifestyle care recommen­
dation. The placebo group received a 
standard care lifestyle recommendation. 
Mean body weight loss was greater in the 
lifestyle group relative to the metformin 
and placebo groups (−5.6, −2.1, and −0.1 
kg, respectively). 
The DPP intervention was extremely 
effective in reducing the risk of diabe­
tes. The crude incidence of diabetes was 
11.0, 7.8, and 4.8 cases per 100 person 
yeas for placebo, metformin, and lifestyle, 
respectively. Thus, lifestyle intervention 
reduced the risk of diabetes by 58% com­
pared with placebo and by 39% compared
with metformin (Figure 1). Weight loss
was the best predictor of a lower inci­
dence of diabetes.111 Furthermore, with 
every kilogram of weight lost, there was 
a 16% reduction in risk for diabetes.111 
Those who met all lifestyle intervention 
goals had an 89% reduced risk of diabe­
tes. Finally, those who met physical activ­
ity goals without meeting the weight loss 
Figure 1. 
Incidence of diabetes in the placebo, metformin, and lifestyle intervention 
group after 4 years in the US Diabetes Prevention Program. Lifestyle 
intervention reduced the incidence of diabetes by 58% and 39% 
compared with placebo and metformin, respectively (reprinted from 
Knowler et al14; used with permission). 
goal (>7%) decreased the risk of diabe­
tes by 46%. 
In the Finnish DPS16,32 522 overweight 
men and women with impaired glucose 
tolerance were randomly assigned to a 
lifestyle intervention or control group. 
The behavioral goals of the lifestyle 
group were to lose ≥5% of body weight, 
reduce fat intake to <30% of total food 
intake, and exercise for ≥30 min/d. Those 
in the lifestyle group were given guid­
ance on how to accomplish these goals 
and had a visit with a nutritionist 7 times 
during the first year and 4 times each 
year after that. Guidance was individu­
ally tailored to each participant through­
out the intervention. The control group 
received general information about life­
style modifications to reduce the risk for 
type 2 diabetes at the start of the study 
alone. In the lifestyle group compared 
with controls, after 1 year, 43% versus 
13% of participants reduced body weight 
by >5%, 47% versus 26% reduced fat 
intake to <30% of food intake, and 86% 
versus 71 exercised >4 h/wk. In the life­
style group, mean body weight loss
was 4.7% after 1 year versus 0.9% in the
control group. The greater weight loss 
in the intervention group was accompa­
nied by significantly greater decreases in 
blood pressure and concentrations of glu­
cose, insulin, and triglycerides relative to 
controls. Similar to the DPP, the cumula­
tive incidence of diabetes was 58% lower 
in the lifestyle intervention group com­
pared with the control group after 6 years 
(Figure 2), and weight loss was the best 
predictor of remaining free of diabe­
tes. Furthermore, all participants meeting 
at least 4 of 5 prescribed lifestyle goals 
remained free of diabetes. 
Look AHEAD is a multicenter, ongo­
ing randomized study evaluating whether 
an intensive lifestyle intervention low­
ers the risk for cardiovascular morbid­
ity and mortality in 5145 overweight 
or obese individuals with type 2 dia­
betes.15,23,33,34,112,113 Overweight or obese 
adults (BMI > 25 kg/m2) were randomly 
assigned to an intensive lifestyle inter­
vention group or a standard care (con­
trol) group. The 2 main goals of the 
lifestyle intervention are for partici­
pants to lose ≥7% of body weight and 
increase physical activity to ≥175 min/wk 
  
 
Figure 2. 
Proportion of overweight or obese participants without diabetes after 6 
years in the Finnish Diabetes Prevention Study. The risk for diabetes was 
reduced by 58% in the lifestyle intervention group compared with the 
control group (reprinted from Tuomilehto et al16; used with permission). 
using a comprehensive behavioral inter­
vention. The intervention is similar to 
the US DPP. Participants in the lifestyle 
group attended weekly behavioral meet­
ings during the initial 6 months, 3 meet­
ings per month from 6 to 12 months, and 
≥1 meeting per month from years 2 to 4.
The meetings focused on diet (includ­
ing use of meal replacements), physi­
cal activity, and behavioral approaches to 
meet the weight loss goals. After 4 years, 
participants in the lifestyle group, rela­
tive to controls, had a greater percent­
age of weight loss (−6.15% vs −0.88%, 
respectively) and greater mean change 
in glycated hemoglobin (HbA
1c
; −0.36% 
vs −0.09%, respectively), systolic blood 
pressure (−5.33% vs −2.97%, respec­
tively), triglycerides (−25.56% vs −19.75%, 
respectively), HDL cholesterol (3.67% 
vs 1.97%, respectively), and cardiorespi­
ratory fitness (+12.74 vs 1.96%, respec­
tively). Moreover, in the lifestyle group 
compared with controls, after 4 years, 
35% versus 18% of participants reduced 
weight by ≥7% weight, and 23% versus 
10% of participants reduced weight by 
≥10% weight (Figure 3).114 Furthermore, 
participants in the lifestyle intervention 
had lower medication use and lower 
costs to treat CVD risk factors.33 These 
data clearly show that a comprehen­
sive behavioral intervention can promote 
long-term weight loss and improve CVD 
risk factors in overweight or obese men 
and women with type 2 diabetes. The 
ongoing intervention over the next 
7 years will determine whether CVD mor­
tality is lower in the lifestyle group. 
Look AHEAD has documented the ben­
eficial effects of weight loss on glycemic 
control in individuals with type 2 diabe­
tes. However, other randomized studies 
using less-intensive dietary interventions 
in individuals with or without diabe­
tes have shown no significant improve­
ments in HbA
1c
 levels with modest weight 
losses (−0.8 to −4.6 kg).115-119 Brinkworth 
et al115 showed that 12 weeks of energy 
restriction resulted in weight loss of 5.3 
kg and lower HbA
1c
 levels. At 64 weeks, 
the average weight loss was -2.9 kg, 
yet HbA
1c
 levels had increased to base­
line levels. Redmon et al118 found that a 
dietary intervention for 2 years resulted 
in a weight loss of 4.6 kg, but HbA
1c
 lev­
els were not significantly lower than 
at baseline. These studies suggest that 
low-intensive lifestyle interventions may 
have less of an impact on glycemic con­
trol compared with more comprehensive 
behavioral interventions that target both 
diet and physical activity, as was done in 
Look AHEAD. 
In sum, the Finnish DPS, US DPP, and 
Look AHEAD provide strong support that 
long-term comprehensive lifestyle mod­
ification can prevent or delay the pro­
gression of prediabetes to diabetes and 
improve type 2 diabetes and CVD risk 
factors. Taken together, these data sug­
gest that (1) lifestyle modification, with a 
modest amount of weight loss (5%-7%), 
reduces the incidence of diabetes by up 
to 58%; (2) weight loss is the best predic­
tor of reduced risk for diabetes; (3) meet­
ing prescribed lifestyle goals substantially 
lowers the risk for diabetes; (4) increased 
physical activity, with modest weight 
loss, independently lowers the risk for 
diabetes; and (5) in adults with type 2 
diabetes, modest weight loss improves 
glycemic control, improves CVD risk fac­
tors, and decreases medication use. 
Long-Term Successful 
Weight Loss 
Even though many overweight or obese 
individuals are able to achieve weight 
loss, many regain lost weight within 2 to 
5 years after treatment termination.120-122 
Whether the high degree of recidivism 
after weight loss is a result of biologi­
cal or behavioral factors remains unclear. 
Some investigators conclude that weight 
regain is inevitable as a result of strong 
biological pressures to return to an obese 
body weight.123 For example, weight loss 
generally alters peripheral hormones 
in a direction expected to stimulate 
food intake and promote body weight 
regain.124,125 Cummings et al124 observed 
  
 
 
 
Figure 3. 
Percentage of participants in diabetes support and education (DSE; controls) and intensive lifestyle 
intervention (ILI) groups who at 4 years met different categorical weight losses in Look AHEAD. Significantly 
greater percentage of participants in ILI, relative to controls, met each of the categorical weight losses shown 
(P < .0001; reprinted from Wadden et al114; used with permission). 
that a 17% weight loss was associated 
with a 24% increase in ghrelin concen­
trations, indicating more stimulus to eat. 
Sumithran et al125 found that 1 year after 
14% weight loss, the hormonal response 
was altered (higher ghrelin, lower leptin, 
and insulin) in a direction expected 
to stimulate food intake and promote 
weight regain. Taken together, these data 
suggest that overweight or obese individ­
uals who lose weight have a strong phys­
iological drive to regain lost body weight. 
On the other hand, other researchers 
believe that weight regain is a result of 
the inability to maintain behavior changes 
in the long term126 or a result of environ­
mental relapse, in which it is impossible 
to maintain appropriate diet and physical 
activity patterns within an environment 
that promotes energy intake and discour­
ages physical activity.127 Clearly, there 
is more work to be done in this area of 
understanding the relative role of behav­
ioral and metabolic factors in predicting 
weight gain and weight maintenance. 
It is interesting to note that although 
there is great pessimism surrounding 
the issue of long-term successful weight 
loss, this belief does not appear to be 
well substantiated. In the Look AHEAD 
lifestyle intervention, for example, 37% 
lost at least 10% of their body weight at 
year 1 and 23% continued to maintain a 
weight loss of at least 10% of their body 
weight at 4 years (Figure 3). Similarly, 
several epidemiological studies suggest 
that approximately 1 out of 3 overweight 
individuals are successful at maintain­
ing a 5% to 10% weight loss for 1 year 
or more.128,129 Thus, there may be greater 
levels of success than is often recognized. 
In an effort to learn more about suc­
cessful weight loss maintenance, Hill and 
Wing established the National Weight 
Control Registry (NWCR) in 1994.130 The 
registry enrolls individuals who are older 
than 18 years and who report having lost 
at least 30 pounds and kept it off for at 
least 1 year. There are currently 10 000 
individuals in the NWCR. Although this 
is not a representative sample of all suc­
cessful losers, it provides a rare opportu­
nity to examine weight loss maintenance. 
The registry members are 77% women, 
82% college educated, 95% Caucasian, 
and 64% married; average age is 46.8 
years. Participants report having lost an 
average of 33 kg, reducing from a BMI of 
36.7 kg/m2 to 25.1 kg/m2 and maintaining 
a weight loss of at least 30 lb for an aver­
age of 5.7 years; 13% have maintained 
the weight loss for at least 10 years. 
Thus, by any criterion, these individuals 
are clearly successful. 
Nearly all the NWCR members reported 
using both diet and physical activity to 
lose weight and keep it off.130 Reported 
calorie and fat intake were low (aver­
aging 1380 kcal/d with 24% as fat), and
exercise levels were very high (2800 kcal/ 
wk). These data underscore the impor­
tance of these 2 behavioral strategies for
long-term weight control. The successful
weight loss maintainers also reported fre­
quent self-weighing—typically daily131— 
consistency in their diet across weekdays, 
weekends, and holidays,132 and low levels 
of television viewing.133 They also report 
a healthy home food and exercise envi­
ronment with significantly more pieces 
of exercise equipment and healthy foods 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
in visible locations in the home than an 
overweight control group.134 Findings 
from the NWCR suggest that success­
ful weight loss maintenance is possible 
through hard work and dietary and exer­
cise vigilance. 
Newer Treatment 
Modalities 
Short- and long-term behavioral inter­
ventions are clearly successful at reduc­
ing body weight. However, these 
interventions typically require substantial 
face-to-face visits, are not available to the 
public, and are difficult to disseminate 
and costly to implement. Internet-based 
interventions may potentially lower the
costs of traditional face-to-face behav­
ioral interventions. In one of the first
randomized, short-term studies, Tate
et al135 assigned 91 overweight adults 
to an Internet education (control) or 
Internet behavioral intervention group. 
The Internet behavioral intervention con­
sisted of 24 weekly lesson plans via 
e-mail and weekly online submission of 
food diaries. Weight loss was significantly 
greater at 3 and 6 months in the Internet 
intervention relative to controls (4.1 kg vs 
1.6 kg, respectively), suggesting that an 
online behavioral approach can produce 
clinically significant weight loss. 
Subsequent studies have compared 
online versus traditional face-to-face 
interventions. In the weight loss mainte­
nance trial,136 participants who had lost at 
least 4 kg during the initial 6-month pro­
gram were randomly assigned to either 
an interactive technology–based main­
tenance program, a personal contact
intervention (monthly phone contacts
and quarterly in-person sessions), or a
minimal contact control. The in-
person program produced the best long-
term results, with no difference between 
the other 2 conditions. Similarly, face-to­
face contact was also most effective in 
the STOP Regain trial.137 In this trial, par­
ticipants were recruited after having lost 
weight either on their own or through 
any type of program. They were then 
offered an 18-month self-regulation pro­
gram designed to help them maintain 
their weight losses. The program taught 
participants to self-weigh daily and to use 
the information from the scale to deter­
mine if adjustments in diet and activity 
were needed. Those who were randomly 
assigned to receive the program through 
monthly face-to-face meetings had better 
outcomes than those who received the 
program via the Internet, with the poor­
est results in those in the control group. 
Although greater weight losses are often
seen in face-to-face compared with online
modalities, Internet-based interventions
nonetheless produce clinically significant
weight losses (>5%) that are maintained
over time.85,99,138-142 Moreover, an appealing
aspect of Internet interventions is the cost-
effectiveness relative to standard behav­
ioral interventions. Krukowski et al143 
recently found that a standard behavioral
intervention with substantial face-to-face
contact cost $372 per person, whereas an
Internet intervention cost $158 per per­
son. The main difference in cost was
participant travel time, and the Internet
intervention substantially lowered this bur­
den. Thus, preliminary data suggest that
Internet behavioral interventions are suc­
cessful at lowering and maintaining body
weight in a cost-effective manner. 
Other emerging approaches to promot­
ing weight loss and maintenance include 
use of text messaging and smart phone 
applications. Patrick and colleagues144 
evaluated the efficacy of a weight loss 
intervention delivered via text messag­
ing on mobile phones and found, after 
4 months, that the intervention group 
lost more weight than the control group 
(2-kg difference). Other ongoing random­
ized studies145-147 are evaluating the effects 
of smart phone applications designed to 
alter diet and physical activity. Coons 
et al145 compared whether a smartphone 
weight loss system, designed to promote 
self-regulation and adherence, is better 
than a standard face-to-face behavioral 
intervention. Others are currently assess­
ing whether interactive digital games 
and new movements (exergaming) may 
increase energy expenditure and pro­
mote weight loss.147 Clearly, this line of 
research is in its infancy but exciting for 
its potential to increase dissemination 
and, potentially, the efficacy of existing 
interventions. 
Weight Loss Counseling 
in the Clinic Setting 
For practitioners treating an obese 
patient with or without type 2 diabe­
tes, a critical question is, “How do I 
incorporate these behavioral interven­
tions into my practice?” Practitioners face 
multiple barriers to effectively deliver­
ing behavioral treatment, including lim­
ited coverage by insurance, limited time 
and training in behavioral techniques 
and obesity treatment, competing needs 
to handle co-occurring medical issues, 
and perceived lack of interest on the 
part of their patients.148 Although avail­
able data do not yet indicate how best to 
incorporate providers in more intensive 
approaches to achieve successful weight 
loss,149 exciting innovations are under 
way.150,151 Moreover, practitioner advice 
can have a powerful impact on a patient 
initiating weight loss efforts. Galuska and 
colleagues152 found that physician advice 
to lose weight led to a 3-fold increase in 
patients’ attempts to address their weight. 
Several government bodies and panels 
have come up with recommendations on 
how physicians and other practitioners 
can best address overweight in clinical 
practice.153-158 Here, we highlight the fol­
lowing key points: 
1. In discussing weight with patients, 
consider the terms used to describe 
excess weight. Wadden and Didie159 
conducted a survey of obese patients 
and found that patients’ least desirable 
terms for referring to their weight 
included Fatness, excess fat, obesity, 
and large size. The more desirable 
terms were weight, heaviness, BMI, 
and excess weight. 
2. Make specific calorie 
recommendations (eg, 1200-1800 
kcal/d) and progressive exercise goals 
leading to the ultimate goal of 60 to 
90 minutes of activity per day. Diet and
exercise goals should be achievable,
with the initial goal of modest weight
loss (7%-10%). Also, patients should be
encouraged to start monitoring daily
food intake, exercise, and weight. 
3. Practitioners should refer obese 
patients to other practitioners (eg, 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
  
dieticians, psychologists, and exercise 
physiologists) or commercial weight 
loss programs for additional support 
and guidance. In a multicenter study, 
Heshka and colleagues160 found 
that participants in Weight Watchers 
lost 5.3% of their initial weight at 1 
year and maintained a loss of 3.2% 
at 2 years, compared with 1.5% 
and 0%, respectively, among those 
who received self-help materials. 
Commercial programs remain a 
potential avenue for supplemental 
help, although additional research is 
clearly needed in this area.161 
4. Continue to meet with patients and 
discuss weight and behavior changes 
on a regular basis. Practitioners can 
support patients’ weight loss efforts 
by reviewing changes in weight and 
health complications at regularly 
scheduled office visits and by 
monitoring patients’ efforts to improve 
their eating and activity behaviors.161 
Success in weight loss should be 
reinforced and praised, and setbacks 
should be met with empathy and with 
encouragement to maintain weight 
control efforts. 
The National Institutes of Health is
currently funding ongoing interven­
tions focused on clinic-based support
for patients to lose body weight.150,151 
The premise behind this funding is
that physicians may have a profound
impact on the success of their patients’
weight loss, but contact with the
patient is limited and typically involves
many other medical concerns or priori­
ties. Christian and colleagues150,151 have
developed a brief, computer-based pro­
gram that provides feedback to patients
on improving barriers to diet and
physical activity. Preliminary data are
encouraging because overweight adults
achieved an average 1.6% (−1.6 kg)
weight loss over 12 months. Moreover,
26.3% of adults in the intervention sus­
tained weight loss of ≥5%. In the not­
so-distant future, computer and other
programs similar to this one may be
available to providers to help their
patients lose weight and reduce the risk
for chronic disease. 
Conclusions and 
Future Directions 
Comprehensive lifestyle interventions 
are clearly successful at promoting long-
term weight control and lowering the risk 
for type 2 diabetes and associated com­
plications. Modest weight losses (5%­
10%) may have a profound impact on the 
risk for diabetes in adults. Moving for­
ward, there are several promising areas 
of investigation. Here, we highlight 3 
areas. 
Prevention 
There are several areas to pursue for 
the primary prevention of obesity and 
type 2 diabetes. Although not the focus 
of this review, prevention of obesity in 
children has become a major area of 
interest.162 Obesity in childhood is asso­
ciated with obesity in adulthood; the 
older the child, the stronger the associa­
tion between childhood and adulthood 
weight status. Moreover, childhood obe­
sity is associated with the same health 
consequences as adult obesity, including 
increased risk of developing type 2 dia­
betes. There are some promising inter­
ventions for prevention of weight gain 
in children and adolescents20 but new 
advances and more effective and dissem­
inable programs are clearly needed.21 
Given the high prevalence of obesity 
and type 2 diabetes in minority popula­
tions, development of effective interven­
tions for at-risk, underserved populations 
is also critical. More research is needed to 
examine the impact of culturally adapted 
weight loss and weight gain prevention 
approaches, taking into consideration the 
ways in which minority populations inter­
act with the health care system, school 
system, and community settings. 
Finally, the time surrounding pregnancy 
is another understudied and potentially 
powerful “teachable moment” for obesity 
and diabetes prevention.163 Gestational 
diabetes (GDM) is a strong risk fac­
tor for the development of type 2 diabe­
tes in women. An estimated 3% to 70% 
of women with GDM will develop type 
2 diabetes within 15 years after the birth 
of their child.164-167 Women with recur­
rent GDM and obesity are at even greater 
risk of developing type 2 diabetes.168,169 
Preliminary research from epidemiologi­
cal and bariatric surgery studies suggests 
that development of GDM may be pre­
vented by reducing prepregnancy body 
weight.170-173 However, future research is 
needed to examine the effects of lifestyle 
interventions before pregnancy to reduce 
body weight and prevent GDM. More 
research has been done during preg­
nancy, and initial findings suggests that 
helping women gain the recommended 
amount during pregnancy through 
healthy eating and physical activity could 
make a major contribution to preventing 
postpartum weight retention, particularly 
in normal weight women.174-176 However, 
more randomized controlled trials are 
needed to identify the effects of lifestyle 
interventions on maternal/fetal outcomes 
and the most effective and disemminable 
interventions during pregnancy, particu­
larly for obese women. 
Maintenance of Long-term 

Weight Control
 
Weight loss is clearly effective in pre­
venting and treating a variety of health
problems, including type 2 diabetes.
Moreover, over the past several decades,
our ability to help overweight/obese
patients lose weight has significantly
improved. Nonetheless, over time, there
is gradual weight regain, with an average
weight loss of 4 to 5 kg at the 3- to 4-year
follow-up. Many individuals fail to main­
tain a ≥5% weight loss. It is critical that
we better understand the environmental,
physiological, and psychosocial variables
that make it difficult to maintain weight
loss in the long term and lead to this
gradual regain. Efforts to overcome these
barriers with new behavioral approaches
may lead to better long-term outcomes. 
Dissemination 
Lifestyle programs can have impor­
tant health benefits, but they are still not
readily available to many overweight or
obese individuals. Further research is
needed to determine how best to dis­
seminate these programs. As noted ear­
lier, of particular interest is the role of
technology in expanding the audience
who could participate. Whether these 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
programs should be covered by insur­
ance programs is another important pub­
lic health issue. Efforts are also needed to 
document the outcomes that participants 
experience in commercial weight loss 
programs, including both face-to-face and 
Internet approaches, in order to deter­
mine what role these programs can play 
in combating the obesity epidemic. 
It is critical that practitioners continue to
work with scientists and policy makers
using a multidisciplinary approach to fur­
ther understand how best to prevent and
treat obesity and its profound health con­
sequences, including type 2 diabetes. AJLM 
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